Interactions between the thyroid hormones and the hormones of the growth hormone axis

Pediatric Endocrinology Reviews

Volumn 1, Issue SUPLL. 2, 2003, Pages 244-250

  Laron, Zvi ^a,b   Ozon A ^c   Neyzi, O ^c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NONE

Author keywords

Acromegaly; GH; GH deficiency; Graves disease; Growth hormone; Hyperthyroidism; Hypothyroidism; IGF I; IGF I treatment; Laron syndrome; Thyroid cancer; Thyroid hormones

Indexed keywords

GHRELIN; GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN; THYROID HORMONE; THYROXINE;

ACROMEGALY; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE GROWTH; BONE MATURATION; CONFERENCE PAPER; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ENERGY EXPENDITURE; GRAVES DISEASE; GROWTH HORMONE DEFICIENCY; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; LARON SYNDROME; NONHUMAN; RAT; SHEEP; THYROID CANCER; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL;

ANIMALS; GROWTH HORMONE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN-LIKE GROWTH FACTOR I; THYROID GLAND; THYROID HORMONES;

EID: 13444272035     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part I. Diagnosis of growth hormone deficiency. GH & IGF Res 2001;11:137-165
2. Robson H, Siebler T, Shalet SM, Williams GR. Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr Res 2002;52:137-147
3. Garcia A, Alvarez CV, Smith RG, Dieguez C. Regulation of Pit-1 expression by Ghrelin and GHRP-6 through the GH secretagogue receptor. Mol Endocrinol 2001;15:1484-1495
4. Kojima M, Hosoda H, Date Y, Nakazoto, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660
5. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hormone deficiency on Ghrelin. Eur J Endocrinol 2002;147:159-163
6. Dalkjaer Riis AL, Hansen TK, Moller N, Weeks J, Jorgensen JOL. Hyperthyroidism is associated with suppressed circulating Ghrelin levels. J Clin Endocrinol Metab 2003;88:853-857
7. Janssen JAMJL, van der Toorn FM, Hofland LJ, van Koetsveld P, Broglio F, Ghigo E, Lamberts SWJ, van der Lely AJ. Systemic Ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 2001;145:711-716
8. Fowden AL, Silver M. The effects of thyroid hormones on oxygen and glucose metabolism in the sheep fetus during late gestation. J Physiol (Lond) 1995;482:203-213
9. Forhead AJ, Li J, Gilmour RS, Dauncey MJ, Fowden AL. Thyroid hormones and the mRNA of the GH receptor and IGFs in skeletal muscle of fetal sheep. Am J Physiol Endocrinol Metab 2001;282:E80-E86
10. Forhead AL, Li J, Sounders JC, Dauncey MJ, Gilmour RS, Fowden AL. Control of ovine hepatic growth hormone receptor and insulin-like growth factor I by thyroid hormones in utero. Am J Physiol Endocrinol Metab 2000;278:E1166-E1174
11. Ramos S, Goya L, Martin MA, Escriva F, Pascua-Leone AM. Influence of hypothyroidism on circulating concentrations and liver expression of IGF-binding proteins mRNA from neonatal and adult rats. J Endocrinol 2002;172:363-373.
12. Ramos S, Goya L, Alvarez C, Pascua-Leone AM. Mechanism of hypothyroidism action on insulin-like growth factor-I and II from neonatal to adult rats: Insulin mediates thyroid hormone effects in the neonatal period. Endocrinology 1998;139:4782-4792
13. Letarte J. The hypothyroid infant: clinical aspects. Pediatr Adolesc Endocrinol 1985;14:117-126
14. Zamboni G, Antoniazzi F, Tato L. Insulin-like growth factor binding protein-3 proteolysis and growth of athyreotic infants in the first weeks of life. Acta Paediatr 2000;89:1050-1055
15. Purandare A, Ng LC, Godil M, Ahnn SH, Wilson TA. Effect of hypothyroidism and its treatment on the IGF system in infants and children. J Pediatr Endocrinol Metab 2003;16:35-42
16. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron type dwarfism. Proc Nat Acad Sci USA 1989;86:8083-8087
17. Cassio A, Cacciari E, Balsamo A, Colli C, Pasini A, Salvioli G, Lanari M, de Lasio R, Boschi S, Pirazzoli P. Low growth hormone binding protein in infants with congenital hypothyroidism. J Clin Endocrinol Metab 1988;83:3643-3646
18. Antoniazzi F, Zamboni G, Mengatrda F, Valentini R, Tato L. Serum GHBPs, IGFs and IGFBPs in congenital hypothyroidism during the first months of therapy. Horm Res 1996;46 (Suppl 2):1-135
19. Elder DA, Karayal AF, d'Ercole AJ, Calikoglu AS. Effects of hypothyroidism on insulin-like growth factor-I expression during brain development in mice. Neurosci Lett 2000;293:99-102
20. Laron Z. Growth hormone and insulin-like growth factor-I: Effects on the brain. Chapter 85. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT, eds. Hormones, Brain and Behavior. San Diego, USA:Academic Press, 2002;75-96
21. Iglesias P, Bayon C, Mendez J, Gonzalez Gancedo P, Grande C, Diez JJ. Serum insulin-like growth factor type I, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction. Thyroid 2001;11:1043-1048
22. Lee WM, Diaz-Espineira M, Mol JA, Rijnberk A, Kooistra HS. Primary hypothyroidism in dogs is associated with elevated growth hormone release. J Endocrinol 2001;168:59-66
23. Ng LLC, Long CH, Bereket A, Purandare A, Smaldone A, Wilson TA. Effect of hyperthyroidism on insulin-like growth factor (IGF-I) and IGF binding proteins in adolescent children. J Pediatr Endocrinol Metab 2000;13:1073-1080
24. Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Monan S, Baylink DJ, Stern PH. Serum insulin-like growth factor-1, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid 2000;10:417-423
25. Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heller SR, Camacho-Hubner C, Gibson JM, Westwood M, Ross RJM. Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism. Clin Endocrinol 2000;52:187-195
26. Ramos S, Goya L, Alvarez C, Martin MA, Pascua-Leone AM. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats. J Endocrinol 2001;169:111-122
27. Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjers A. Free and total insulin-like growth factor (IGF)-I, -II and IGF binding protein-1,-2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab 2003;88:132-135
28. Hansson HA, Petruson B, Skottner A. Somatomedin C in the pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1986;1:218-219
29. Hansson HA, Aspects on growth factors in exophthalmos. Acta Endocrinol (Copenh) 1989;21(Suppl 2):107-111
30. Krassas GE. Somatostatin analogues in the treatment of thyroid eye disease. Thyroid 1998;8:443-445
31. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci 1966;2:152-155
32. Laron Z, Pertzelan A, Karp M. 1968 Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968;4:883-894
33. Laron Z. Prismatic cases:Laron syndrome (primary growth hormone resistance) From patient to laboratory to patient. J Clin Endocrinol Metab 1995;80:1526-1573
34. Laron Z. Laron Syndrome (primary GH resistance or insensitivity). The personal experience 1958-2003. J Clin Endocrinol Metab 2004 (in press)
35. Klinger B, Ionesco A, Anin S, Laron Z. Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects. Acta Endocrinol (Copenh) 1992;127:515-519
36. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A. Reduced levels of thyroid hormones, insulin and glucose, and lower body core temperature in growth hormone receptor/binding protein knockout mouse. Exp Biol Med 2001;226:552-558
37. Poretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arioso M, Beck-Peccoz P on behalf of Eli Lilly and Co B9R-EW-GDED Italian Study Group. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: When does L-T4 therapy become mandatory? J Clin Endocrinol Metab 2002;87:2042-2045
38. Wyatt DT, Gesundheit N, Sherman B. Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: Lack of need for thyroxine supplementation? J Clin Endocrinol Metab 1998;83:3493-3497
39. Connolly CM, Barrow RE, Chinkes DL, Martinez JA, Herndon DN. Recombinant human growth hormone increases thyroid hormone-binding sites in recovering severely burned children. Shock 2003;19:399-403
40. Pellizas CG, del Mar Montesinos M, Masini-Repiso AM, Torres AI, Coleoni AH. Differential modulation of liver and pituitary triiodothyronine and 9-cis retinoid acid receptors by insulin-like growth factor in rats. Thyroid 2002;12:1071-1078
41. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A. Prevalence of thyroid diseases in patients with acromegaly: result of an Italian multicentric study. J Endocrinol Invest 2001;25:240-245
42. Bogazzi F, Manetti L, Bartalena L, Gasperi M, Grasso L, Cecconi E, Rago T, Pinchera A, Martino E. Thyroid vascularity is increased in patients with active acromegaly. Clin Endocrinol 2002;57:65-70
43. Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol 1997;46:545-549
44. Clement S, Refetoff S, Robaye B, Dumont JE, Schurmans S. Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-I receptor in the thyroid gland. Endocrinology 2001;142:5131-5139
45. Rivkees SA, Bode HH, Crawford JD, Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J 1988;318:599-602
46. Weiss RE, Refetoff S. Effect of thyroid hormone on growth. Lessons from the syndrome of resistance to thyroid hormone. Endocrinol Metab Clin North Am 1996;25:719-730
47. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM. Special features of Grave's disease in early childhood. Thyroid 1999;9:871-877
48. Lewinson D, Harel Z, Shenzer P, Silbermann M, Hochberg Z. Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone. Endocrinology 1989;124:937-945
49. Lewinson D, Bialik GM, Hochberg Z. Differential effects of hypothyroidism on the cartilage and the osteogenic process in the mandibular condyle. Recovery by growth hormone and thyroxine. Endocrinology 1994;135:1504-1510
50. Bohme K, Conscience-Egli M, Tschan T, Winterhalter KH, Bruckner P. Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine. J Cell Biol 1992;116:1035-1042
51. Siebler T, Robson H, Shalet SM, Williams GR. Glucocorticoids, thyroid hormone and growth hormone interactions: implications for the growth plate. Horm Res 2001;56(Suppl 1):7-12
52. Sato T, Suzukui Y, Taketani T, Ishiguro K, Masuyama T. Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Metab 1977;45:324-329
53. Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y, Ozasa A, Nakao K. Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endrochonal ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. J Bone Miner Res 2002;17:443-454
54. Huang BK, Golden LA, Tarjab G, Madison LD, Stern PH. Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res. 2000;15:188-197
55. Pepene CE, Kasperk CH, Pfeilschifter J, Borcsok I, Gozariu L, Ziegler R, Seek T. Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro. Bone 2001;29:540-546
56. Vannelli GB, Barni T, Modigliani U. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990;71:1175-1182
57. van der Laan BF, Freeman JF, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995;5:67-73
58. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. The IGF system in thyroid cancer: new concepts. J Clin Pathol:Mol Pathol 2001;54:121-125
59. Takahashi MH, Thomas GA, Williams ED. Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas. Br J Cancer 1995;72:813-817
60. Maiorano E, Ciampolillo A, Viale G, Maisonneuve P, Ambrosi A, Triggiani Marro E, Perlino E. Insulin-like growth factor I expression in thyroid tumors. Appl Immunohistochem Mol Morphol 2000;8:110-119
61. Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid 1995;5:47-50
62. Barzilay J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991;151:1629-1632
63. Jorgensen JOL, Wolthers T, Weeke J. Growth hormone and thyroid function and energy expenditure. In: Juul A, Jorgensen JOL, ed. Growth Hormone in Adults. Physiological and Clinical Aspects, 2nd ed. Cambridge, UK: University Press, 2000, pp. 498